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Summary
Although thyroglobulin (Tg), the thyroid prohormone, is well known as a T cell dependent
autoantigen in human and experimental autoimmune thyroid disease, very little isknown about
the molecular basis of Tg recognition byT cells. In this paper, we have characterized the epitopes
recognized by .two clonotypically distinct, murine Tg autoreactive T cell hybridomas, CH9 and
ADA2 . In vitro iodination of a Tg preparation which was deficient in in vivo organified iodine
was first used to confirm our previous observation that these T cells recognize iodination-related
epitopes in the Tg molecule . Affinity chromatography of tryptic peptides derived from normally
iodinated human Tg revealed that these epitopes were exclusively located in thyroxine (T4) containing
peptides. Through the use of synthetic T4-containing peptides, representing the four major
hormonogenic sites in Tg, we demonstrated that both CH9 and ADA2 recognize an epitope
containing the T4 at position 2553 in human Tg . Sets of overlapping 5mer to 12mer peptides
around this T4 showed that the most potent peptide was a 9mer beginning at Asp 2551 . The
T4 was shown to be a critical residue, since its replacement with any ofthe 20 naturally occurring
amino acids produced only nonstimulatory peptides. Since the T cell hybridomas could also be
stimulated by major histocompatibility complex class II positive (interferon-,y-treated) thyroid
epithelial cells in vitro, and their parent T cell lines can induce thyroiditis on adoptive transfer,
the T4-containing Tg sequence described here is implicated as a pathogenic epitope in murine
thyroid autoimmunity .
T
he production of the thyroid hormones thyroxine (T4),t
tri-iodothyronine (T3) and reverse T3 (rT3) is depen-
dent on the organification ofiodine into thyroglobulin (Tg),
the major protein product of the thyroid (1, 2) . This involves
thyroid peroxidase catalyzed iodination of tyrosine residues
in Tg to form mono- and di-iodotyrosines and their subse-
quent crosslinking to form the iodothyronines T3 and T4.
These mature Tg molecules are stored in a colloidal form in
the lumen of thyroid follicles. Secretion of T4 and T3 in-
volves the endocytosis and subsequent proteolysis of colloidal
Tg, which releases the hormone residues for diffusion into
the circulation . The recent cloning of the genes coding for
Tg from several species has allowed the precise localization
1 Abbreviations used in this paper. HTg, human thyroglobulin; MTg, mouse
thyroglobulin ; TEC, thyroid epithelial cells ; Tg, thyroglobulin; T3, tri-
iodothyronine; T4, thyroxine ; rT3, reverse tri-iodothyronine ; TSH, thyroid
stimulating hormone.
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of the four main hormonogenic sites within the molecule
(3-5) . In human Tg, tyrosines at positions 5, 2553, 2567 and
2746 of the 2748 amino acid monomer may be modified to
form T4 or T3 residues. Under conditions of limited iodine
availability, hormonogenesis occurs preferentially at position
5 near the N-terminus (6, 7) . Factors other than iodine levels
whichmay regulate the degree ofhormonogenesis at the other
sites are not clear. However, some evidence suggests that po-
sition 2746 may be preferentially converted toT3 rather than
T4 (8) .
Tg has been known for over three decades as an autoan-
tigen in human and experimental autoimmune thyroid dis-
ease (1, 9-11) . Epidemiologic and experimental evidence has
indicated that the autoantigenicity ofTg may be influenced
by its iodine content. For example, raised dietary iodinelevels
inhumans (12-14) and experimental animals (15-19) has been
correlated with an increase in the incidence and severity of
autoimmune thyroid lesions . In chickens, highly iodinated
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than poorly iodinated Tg (20), while in mice, inhibition of
the peroxidase reaction with aminotriazole produces very
poorly iodinated Tg which fails to elicit autoimmune thy-
roiditis in high responder CBA/J mice (21) . To date, it is
not clear whichofthe many iodination sites in Tg arerespon-
sible for these effects on Tg antigenicity or how they are
mediated .
However, our recent observation that two clonotypically
distinct autoreactive murine T cell hybridomas recognized
iodination-dependent epitopes in Tg (21) provided a clue to
the molecular basis ofTg autoantigenicity. We now report
that both ofthese T cells recognize a T4-containing peptide
centered on the hormonogenic site at residue 2553 inhuman
Tg, and that this epitopeis expressedon the surfaceofmouse
thyroid epithelial cells (TEC) cultured with IFN- ,y.
Materials and Methods
Thyroglobulin Preparations.
￿
MouseTg (MTg)wasprepared from
pooled thyroids andhumanTg (HTg)from individual post-mortem
thyroids as previously described (22). The levels of organified io-
dine and thyroid hormone residues in Tg preparations were deter-
mined as described elsewhere (23) .
Thyroglobulin Iodination.
￿
HTg of low iodine content (TgMC,
0.08 T4 residues/mole) was iodinated with Nal by the Iodogen
method (24), with reaction times of 10-80 min (transferring the
mixture to fresh iodogen-coated tubes every 10 min) to produce
preparations (TgMCI-6) differing in their levels of organified io-
dine and T4 residues.
Preparation ofTg Peptides.
￿
HTgwasreduced and alkylatedwith
iodoacetamide in 8Murea (25), dialyzed to remove the urea, digested
with TPCK-Trypsin (Sigma Chemical Co., Poole, UK) at an en-
zyme:substrate ratio of 1:50 in 0.1Mammonium bicarbonate for
4 h . The digest was lyophilized and redissolved in 20mM sodium
phosphate, pH 7.4 to 1 mg/ml andpassed through an affinity ma-
trix consisting of rabbit anti-T4 anti-bodies (Miles, Stoke Poges,
UK) coupled to tosyl activated Sepharose4B (26) . Unadsorbed pep-
tides (T4- ) were collected . Adsorbed peptides (T4*) were recov-
eredby elution with 0.1Mammonia in 10% (v/v) ethanol, lyophi-
lized and reconstituted to the original column loading volume in
20 mM sodium phosphate, pH 7.4 . The concentrations quoted in
Results for the T4+ peptides represent those of equivalent dilu-
tions of unseparated tryptic peptides.
Synthetic peptides varying in length from 5 to 12 amino acids
were produced on derivatized polyethylene pins as described previ-
ously (27) .
TCells .
￿
The generation, characteristics andmaintenance oftwo
autoreactive murine Tg-specificT cell hybridomas,CH9 andADA2,
have been describedelsewhere (21, 28, 29). Briefly, both were ob-
tained by fusion ofBW5147 cells with mouse Tg-specific, I-A' re-
strictedT cell lines; CH9 was generated from the noncloned line
MTg12B, whereas ADA2 was derived from the T cell clone
MTg9B3 . The T cell receptors expressed by CH9 and ADA2/
MTg9B3 have been shown to be distinct by both T cell receptor
/3 chainrestriction fragment polymorphism(29) and their differential
reactivity with Tgs prepared from thyroids ofdifferent species (28) .
Both hybridomas produce IL2 and not 11,4 on activation with
specific antigen (Champion, B.R ., unpublished observations) . CH9
and ADA2 were cultured inRPMI 1640 supplemented with 10%
FCS, 2mM Irglutamine, 5 x 10-5M 2-ME, 1 mM sodium pyru-
vate, nonessential amino acids (1x ; FlowLaboratories, Irvine, Scot-
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land), 50U/ml benzylpenicillin and56 Ftg/ml streptomycin (RPMI/
10% FCS) . MTg12B and MTg9B3 were maintained by regular cycles
of activation with mouse Tg and antigen presenting cells (APCs :
3000R irradiated syngeneic spleen cells), followed by expansion in
IIr2 containing medium(DMEM supplemented as for RPMI/10%
FCS) as described elsewhere (30) . The IIr2--dependent celllineCTLL
(31) was maintained in RPMI/10% FCS supplemented with 1%
phorbol myristate acetate-stimulated E1,4 supernatant as a source
of IL2 .
IL2 Release Assay .
￿
Specific activation ofCH9 and ADA2 was
measured by their ability to release IL2 in response to different
stimuliin the presence ofAPCs as described elsewhere (29) . Briefly,
1-2 x 105 hybridoma cells were cultured with irradiated (3000 R)
splenic APCs (5 x 10 5 unless otherwise stated) in the presence
of test antigens in 200 IA1 RPMI/10% FCS . After 24-h, 100 P.l
aliquots of supernatant were tested for their 11,2 content by their
ability to support the proliferation of CTLL cells (10'/well) .
Proliferative responseswere assessed by the incorporation of either
'H-thymidine or "'I-deoxyuridine as indicated in the Results. We
have previously shown that both CH9 and ADA2 produce rela-
tively low levels of IL2 which are always nonsaturating for the
CTLL cells when compared with standard IL2 preparations (29) .
Thus, results are simply expressed as incorporation of radiolabel
by the CTLL cells (arithmetic mean cpm ± SD).
Prolferative Responses of T Cell Lines.
￿
Specific activation of
MTg9B3 cells by antigen was directly assessed by the incorpora-
tion of radiolabel during the last 18hofa3-d culture as previously
described (30) . Results are expressed as mean cpm ± SD.
Thyroid Epithelial Cell (TEC) Cultures.
￿
Modification of the
methods ofCreemers et al . (32) and Chiovata et al . (33) were used
toestablish cultures ofmouseTEC. Pooled thyroids fromCBA/Ca
(H-2 t) mice were minced with fine scissors in 5 ml Hank's
balanced salt solution (HBSS) containing 1.5 mg/ml collagenase
(Sigma type IV; Sigma Chemical Co.) and incubated for 1-2 h at
37°C. At regular intervals, the mixture was vigorously pipetted
to aid disruption of the follicles . The suspension was then diluted
to 15 ml in HBSS containing 20% FCS. Following centrifugation
(200g-, 10 min), the cell pellet was resuspended and washed two
times in HBSS/10% FCS . The cells were then suspended in cul-
ture medium (RPMI/10% FCSL) containing sodium iodide (1 IAM),
hydrocortisone (10-s M), bovine insulin (100 IU/ml), bovine
transferrin (5 icg/ml) and HEPES (25 mM) as additional supple-
ments. Because ofclumping it proved difficult to accurately count
the TECs before culture. Therefore, cells prepared from 10-12
thyroids were used to seed one complete 96-well flat-bottomed mi-
crotiter plate (200 pl/well) . After 1 dofculture, nonadherent cells
were removed by extensive washing and the adherent cells recul-
tured in complete medium containing 1% FCS . After 2d culture,
some wells received rat IFN-y (100 U/ml) . At day 5, cells were
washed three times withT cell hybridoma culture medium and
CH9 cells (105/well) added for 24 h . Cell-free supernatants were
then tested for 11,2 as described above . These TEC culture condi-
tions were found to be optimal for the induction of I-A''MHC
class II molecules on the TEC surface by IFN-y, as assessed by
standard immunohistochemical techniques with specific antibodies
(not shown) . Microscopic examination of theTECmonolayers be-
fore addition of hybridoma cells showed them to be free of
mononuclear cells .
Results
Autoreactive Tg-speck ClonedTCellsRecognize lodination-
Dependent Epitopes ofTg.
￿
We have previously reported that
T Cell Recognition of Thyroxine-containing Autoepitopes in Thyroglobulintwo clonally distinct Tg-specific, I-Ak-restricted autoreactive
T cell populations, represented by the hybridomas CH9 and
ADA2 (and the parent clone ofADA2, called MTg9B3), only
recognize Tg which is sufficiently iodinated (21) . These clones
have also been shown to have distinguishable epitope spe-
cificities by their differential responsiveness to a panel of Tgs
prepared from different species (28) . Both could be cross-
stimulated by human Tg, but recognized bovine Tg weakly
or not at all (28) .
To further evaluate the critical role ofiodination in recog-
nition ofTg by these T cells, the Iodogen method was used
to generate iodotyrosine and iodohyronine residues in a poorly
iodinatedhuman Tg preparation (TgMC) . Different incuba-
tion conditions were used to prepare samples (TgMC1-6)
which differed in their total iodine content and theirT4 levels.
The response ofMTg9B3 to these Tg preparations is illus-
trated in Fig. 1 . In contrast to the lack of response to the
poorly iodinated TgMC, MTg9B3 cells responded well to in
vitro iodinated preparations TgMC1-5 . The TgMC6 prepa-
ration failed to stimulateMTg9B3 cells . Similar results were
obtained with the hybridomas ADA2 andCH9 (not shown) .
The lack of response to the most heavily iodinated prepara-
tion (TgMC6), found with all the cells, suggests that exces-
sive iodination in some way blocks processing and presenta-
tion of the critical epitope.
CH9 andADA2/MTg9B3 Recognize Thyroxine-Containing
Tg Tryptic Peptides. To test the importance of T4 residues
to the antigenic site(s) recognized by CH9 and ADA2/
MTg9B3, human Tg was reduced and alkylated followed by
trypsin digestion and affinity chromatography of the tryptic
peptides on an anti-T4 column to produce T4-depleted (T4-)
and T4-enriched (T4') peptide preparations . As previously
reported (1), CH9 responded as well to tryptic peptides as
to native Tg or reduced/alkylated Tg, whereas ADA2 (and
1
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Figure 1 .
￿
In vitro iodination of human Tg oflow intrinsic iodine con-
tent generates the epitope recognized by the autoreactive, 1g-specific mouse
T cell clone, MTg9B3 . Aliquots ofa preparation of human Tg with low
T4 content (TgMC) were iodinated in vitro to produce the preparations
TgMC1-6, whose iodine and T4 contents are shown. Proliferative responses
(mean ± SD) oftriplicate cultures ofMTg9B3 cells to those different Tg
preparations are shown as the incorporation of 1251-deoxyuridine (cpm x
10- 3) . The same response pattern was observed for theT cell hybridomas
CH9 and ADA2 (not shown) .
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MTg9B3, not shown) responded less well to the trypsin di-
gest (Fig . 2) . Affinity chromatography effected a complete
compartmentalization of the stimulatory peptides for both
T cell populations into the T4+ peptide pool . Although
peptides lacking T4 may have non-specifically adsorbed to
the column to become included in the T4+ peptide pool,
this result indicated that the epitope(s) is associated with a
hormonogenic site (as opposed to a sequence containing io-
dotyrosines, or dehydroalanine produced incidentally during
peroxidase-catalyzed Tg modification (1, 34]) .
CH9 andADA2/MTg9B33 Recognize Closely Related Epi-
topes ofHuman Tg Containing T4 at Residue 2553. The results
portrayed in Fig. 2 indicated that the epitopes recognized by
CH9 andADA2 involved one ormore of the fourhormono-
genic sites in Tg (1, 2), or were located close to one of these
sites. The amino acid sequences of these 4 sites in human
Tg are shown in Fig. 3 . To determine which, if any, of these
T4 residues was involved in forming the epitopes for CH9
andADA2/MTg9B3, overlapping sets of 12-amino acid poly-
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Figure2 .
￿
Tg autoreactive T cell hybridomas recognize T4-bearing human
Tg peptides. The responses (1172 release) ofautoreactive T cell hybridomas
CH9 andADA2 to different human Tg antigen preparations are shown .
Separation of trypsin-cleaved Tg peptides according to their T4 content
by affinity chromatography clearly showed that both hybridomas recog-
nize epitopes within the T4-containing (T4+) but not the depleted (T4-)
fraction. IIT2 activities released were assessed in a CTLL proliferation assay
as described in Materials and Methods . Results (mean f SD) are expressed
as 12SI-deoxyuridine incorporation (cpm x 10- 3) of triplicate CTLL
cultures.
w TgMC
I/mol
N .D .
T4/mol
0 .08
TgMC1 24.8 3.08
oTgMC2 14.5 0 .99
oTgMC3 16.5 1.48
oTgMC4 40.8 6.25
-TgMC5 65.0 5.56
-TgMC6 71 .1 4.38T4 sites
Figure 3 .
￿
The positions of the four hormonogenic sites and the sur-
rounding amino acids in the primary sequence of human Tg3 . Amino
acids are representedin single letter code, and the numbers show the posi-
tion of the hormonogenic sites within the Tg primary sequence .
peptides centered on each of the four hormonogenic sites in
the primary sequence ofhuman Tg were synthesized . These
peptides were then tested for their ability to stimulateCH9
and ADA2 cells. The results (illustrated in Fig. 4) clearly
demonstrated that both CH9 and ADA2 recognize an epi-
tope involving theT4 residue at position 2553 . The sequence
surrounding this residue corresponds to a potential T cell
epitope based on two predictive algorhythms (35, 36) . Replace-
ment ofT4 in the sequence with any of the 20 naturally oc-
curring amino acids (including tyrosine) abrogated the ca-
pacity to stimulate bothCH9 (Fig . 5) andADA2 (not shown),
indicating that this T4 is a critical residue for both T cell
hybridomas.
To delineate the boundaries of this epitope, we challenged
the T cell hybridomas with a series of 5 to 12 mer peptides
centered on theT4 at position 2553 . T4-containing peptides
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￿
CH9 andADA2 both recognize an epitope centered on the
T4 residue at position 2553 in human Tg. Sets ofoverlapping T4-containing
12mer peptides, representing the four hormonogenic sites illustrated in
Fig. 3, were synthesized on derivatized polyethylene pins as previously
described (27) . The responses ofCH9 and ADA2 to these peptides (at
2 .5 jug/ml) are shown . The amino acids in each peptide are presented in
one-letter code . Responseswere assessed as described in Fig. 2, except that
the incorporation of 3H-thymidine was used to assess the proliferation of
CTLL cells .
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Amino acid at position X in STDDXASFSRA
Figure 5 .
￿
T4 is essential for peptide recognitionbyCH9 cells. Responses
ofCH9 to 11merpeptides (2.5 ttg/ml) of sequence STDDXASFSRA, where
X is the amino acid or T4 indicated, are shown. The response ofCH9
with no added peptide is also shown (-) . Similar results were obtained
with the 9mer and 10mer sequencesTDDXASFSRA and DDXASFSRA
(not shown) . Responses were assessed as described in Fig . 2 .
of 8 amino acids or less were all non-stimulatory for either
T cell hybridoma at concentrations up to 1.25 F,M (not
shown), as were peptides beginning at Asp 2552 (see Fig.
4) . This indicates that the smallest fully effective epitope is
a T4-containing 9mer. At present we cannot rule out the
possibility that a smaller peptide could stimulate at much
higher concentrations . Fig . 6 shows example dose curves for
both CH9 and ADA2 stimulated with different 9 to 12mer
peptides and summarizes the relative stimulatory capacity of
these peptides in terms ofthe concentration required to achieve
half-maximal stimulation (ED5o) . Deletion of Ala 2559 from
the C-terminus of the peptide abrogated their ability to stimu-
late CH9, but only diminished their activity with ADA2
by 20-30-fold . Elongation of the peptides C-terminal to Ala
2559 consistently diminished the stimulatory capacity for both
T cells, whereas addition of residues N-terminal to Asp 2551
had no appreciable effect on antigenic potency. These obser-
vations, coupled with previous data using a panel ofTgs from
different species (28), indicate that CH9 and ADA2 recog-
nize the same T4-containing epitope in Tg, but have subtly
different structural requirements for optimal stimulation .
Comparison of the published primary sequences of human
(3), rat (4), and cow (5) Tg in this region revealed that the
maximally stimulating 9mer (boxed in Fig. 7) is identical
in all three species.
Mouse Thyroid Epithelial Cells Cultured with IFN-y Express
the Epitope Recognized by CH9. To determine whether the
epitope described above can be expressed by thyroid cells, we
cocultured CH9 with primary cultures of syngeneic TEC,
without addedTg. TEC precultured with IFN-,y , using con-
ditions which induceMHC class 11 expression (not shown)
and increase Tg release (1), were able to stimulate 11,2 produc-
tion by CH9 cells (Fig. 8) . The level of response was gener-
ally low, but similar to that triggered by comparable numbers
T Cell Recognition of Thyroxine-containing Autoepitopes in Thyroglobulin10
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Figure 6 .
￿
Responses ofCH9 andADA2 to T4-containing peptides of
different length representing the hormonogenic site at position 2553 of
human Tg. (A and B) Representative dose-curves of CH9 and ADA2 re-
sponses to the peptides defined inC . (C) The responses ofCH9 andADA2
to the T4-containing peptides shown are represented as the concentration
required to stimulate a half-maximal response (EDso) . Peptides of 5, 6,
7, or 8 amino acids containing the T4 residue were all nonstimulatory
(not shown) . Results represent mean 3H-thymidine incorporation by
triplicate cultures ofCTLL cells . NT = not tested.
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￿
Comparison of the amino acid sequences of r2N, human ;
and cows Tg around the hormonogenic site at position 2553 (2555 in
cow Tg) . The minimal 9mer sequence recognized by CH9 andADA2 is
boxed, as is the N-glycosylation site at position 2562 in human and rat
Tg which is missing in cow Tg.
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￿
The epitope recognized by the T cell hybridoma CH9 can
be expressed by ON-'y-treated syngeneic thyroid epithelial cells (TEC) .
Three experiments demonstrating the activation ofCH9 byTEC precul-
tured with (or without) IFN -'y, to induce MHC class II expression, are
shown . Responses to mouse Tg (MTg) presented by comparable numbers
of splenic antigen presenting cells are shown for comparison . Responses
were assessed as described in Fig . 2 .
of irradiated spleen cells in the presence ofMTg. This indi-
cates that the T4-containing epitope can be generated byTEC
and expressed in association with I-Ak on their cell surface.
In this paper we have shown that two independently de-
rived autoreactive mouse T cell hybridomas both recognize
(albeit slightly differently) the same T4-containing epitope
in Tg. Although we have shown that the T4 residue is crit-
ical for recognition by these hybridomas, it is not yet clear
whether it directly interacts with the T cell receptor or the
I-Ak molecule (or both) . This is a particularly intriguing
question when one considers the extremely large molecular
size ofT4 compared with the rest of the 9mer peptide (mo-
lecular weight of 763 out of a total 1627 for the entire pep-
tide) . Competition studies and molecular modeling will be
required to address this point .
A comparison of the amino acid sequences around this T4,
at position 2553 inhuman Tg, with those around the equiva-
lent site in rat and bovine Tg (the mouse Tg sequence is not
available) provide interesting information regarding the rec-
ognition of this autcantigenic site by CH9 andADA2 (Fig .
7) . As previously reported (29), both CH9 and ADA2 were
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1 P L , R Q G G G G G G , G G >1250 N.T.generated as autoreactive mouse Tg-specificT cells which cross-
reacted well with human and rat Tg, but were only weakly
responsive to bovine Tg (and other members of the Artio-
dactyla family) . However, the sequence containing the min-
imal stimulatory epitope defined above (boxed in Fig. 7) is
identical in all three species. This observation suggests that
sequences outside of the minimal epitope also play a critical
role in generating stimulatory I-Ak/peptide complexes. Since
position 2555 in bovine Tg has been shown to be one of the
major hormonogenic sites (5), it is unlikely that the lack of
reactivity of our T cells to this species ofTg is due to the
lack of a T4 residue at this position (the bovine Tg used had
normalT4 levels) . A more plausible hypothesis is that residues
outside the epitope influence the processing ofTg by antigen
presenting cells . An alternative, but not mutually exclusive,
explanation would be that the naturally processed Tg frag-
ment is larger than the minimal epitope and that residues
included in this fragment influence either the formation or
activity of I-Ak/peptide complexes . The information in Fig.
7 presents two testable explanations for the low potency of
bovine Tg. The replacement of Ser 2549 and Thr 2550 in
human Tg withAsp and Ser, respectively, in bovine Tg might
prevent MHC binding of a peptide containing these residues
or remove/create critical proteolytic cleavage sites. Similar con-
siderations could be given to the Gln for Asn substitution
at position 2562 ; this substitution also removes an N-gly-
cosylation site (known to be glycosylated in humanTg [37])
which could influence intracellular processing events .
The ability of IFN--y stimulatedTECs to activate the hy-
bridoma CH9 without the addition ofTg indicates that the
epitope described here can be functionally expressed by thy-
roid cells, at least in vitro. This observation appears to conflict
with other reports (38-40) that mouse TEC will only present
antigen to T cell lines or hybridomas following the induc-
tion of a poorly defined costimulatory activity. This dis-
crepancy may simply reflect differences in the costimulator
requirements of the cells used ; some T cell hybridomas ap-
pear to lack a requirement for costimulatory signals since they
can be stimulated by isolatedMHC/peptide complexes (41) .
Alternatively, TECsmay be particularly efficient at presenting
the epitope described here since the antigen (Tg) is produced
in relatively large amounts by the cells themselves . Ebner et
al . (39) have shown that TEC could stimulate a class I (Kb)
alloreactive T cell hybridoma, but not class II alloreactive
cells. Although this most likely reflects differences in signalling
requirements between class I- and II-restricted T cells, the
different processing routes usually used to generate the epi-
topes recognized by these cells (42) could also be important .
Class II-restricted T cells which recognize epitopes gener-
ated within the cell from endogenous antigens (the processing
route primarily used by class I-restricted epitopes) have been
described (43) . We are, therefore, in the process ofdetermining
the antigen processing route used byTEC to present the T4-
containing epitope recognized byCH9 cells. Whether or not
thyroid cells can express the relevant epitope in vivo is not
clear at present . However, in preliminary experiments, we
have shown that the T cell line MTg12B (parental line to
CH9) and the clone MTg9B3 can elicit thyroid lesions in
irradiated CBA/J recipients, when transferred 3 days following
activation with antigen in vitro (not shown) . These observa-
tions, coupled with the previously described inability of T4-
deficient Tg to elicit thyroiditis in CBA mice (21), indicate
that T cell recognition of the T4-containing epitope of Tg
described in this paper can have pathological consequences .
A striking feature of the autoantigenic T cell epitope de-
scribed in this paper is that it is generated from Tg in the
target organ by physiologically important post-translational
mechanisms involved in the hormone-forming function of
the gland. The production of this epitope will depend on
the relative availability of iodine in the gland : under condi-
tions of iodine deficiency, very little will be formed due to
hormonogenesis occurring primarily at the N-terminal site
(6, 7) . Since some evidence suggests that circulatingTgmay
be poorly iodinated, particularly in neonates (44-46), T cell
tolerance to the T4-containing epitope may not be effectively
established . This could account for the ease of induction of
both experimental tolerance (47, 48) and autoirnmune thy-
roiditis (49) in mice. It may also help explain the ability of
thyroid stimulating hormone (TSH) to induce tolerance to
Tg in mice (48), since TSH administration has been reported
to stimulate increases in the iodine content of circulating Tg
(50) . Although the importance of T4-containing T cell epi-
topes in human thyroid autoimmunity is unknown, our
findings could provide a molecular basis for the link between
dietary iodine levels and spontaneous thyroid disease, both
in man (12-14) and in animals (15-19) .
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